Work

Role of amifostine as a cytoprotectant in children ≥ 3 years with average risk (AR) medulloblastoma (MB) treated with craniospinal irradiation (CSI) and 4 courses of cisplatin (CDDP)-based high dose chemotherapy

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.9063

Authors: M. Fouladi, M. Chintagumpala, D. Ashley, S. Kellie, A. Broniscer, T. E. Merchant, L. E. Kun, C. Stewart, D. Wallace, A. Gajjar

Institutions: Royal Children's Hospital, Baylor College of Medicine, Children's Hospital at Westmead

Language: English

Topic: Chemotherapy-induced organ toxicity mitigation

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2109848523

Cites:

Cited by:

Related to: 10